Carbapenemase genes among multidrug resistant gram negative clinical isolates from a tertiary hospital in Mwanza, Tanzania

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Mushi, Martha F ^a,b   Mshana, Stephen E ^a   Imirzalioglu, Can ^c,d   Bwanga, Freddie ^b,e  

^a CATHOLIC UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^b MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d Partner Site Giessen Marburg Langen Campus   (Germany)

^e MBN Clinical Laboratories   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CARBAPENEMASE; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; ERTAPENEM; GENTAMICIN; MEROPENEM; BACTERIAL PROTEIN; BETA LACTAMASE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM DETECTION; BACTERIUM ISOLATION; CITROBACTER FREUNDII; DISK DIFFUSION; ENTEROBACTER; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; GENE AMPLIFICATION; GRAM NEGATIVE BACTERIUM; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MORGANELLA MORGANII; MULTIDRUG RESISTANT GRAM NEGATIVE BACTERIUM; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEUS MIRABILIS; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; SALMONELLA; SALMONELLA TYPHI; SERRATIA MARCESCENS; TANZANIA; TERTIARY CARE CENTER; CROSS-SECTIONAL STUDY; DEVELOPING COUNTRY; GENETICS; HOSPITAL; HUMAN; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE; PREVALENCE; PROCEDURES;

BACTERIAL PROTEINS; BETA-LACTAMASES; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIA; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; PREVALENCE; TANZANIA; TERTIARY CARE CENTERS;

EID: 84897910750     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/303104     Document Type: Article

References (29)

1. Moquet O., Bouchiat C., Kinana A., Seck A., Arouna O., Bercion R., Breurec S., Garin B., Class D OXA-48 carbapenemase in multidrug-resistant enterobacteria, Senegal. Emerging Infectious Diseases 2011 17 1 143 144 2-s2.0-78650982838 10.3201/eid1701.100224
2. Pop-Vicas A. E., D'Agata E. M. C., The rising influx of multidrug-resistant gram-negative bacilli into a tertiary care hospital. Clinical Infectious Diseases 2005 40 12 1792 1798 2-s2.0-20444415331 10.1086/430314 (Pubitemid 40799949)
3. Bratu S., Landman D., Haag R., Recco R., Eramo A., Alam M., Quale J., Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Archives of Internal Medicine 2005 165 12 1430 1435 2-s2.0-22144436291 10.1001/archinte.165.12.1430 (Pubitemid 40973427)
4. Brink A. J., Coetzee J., Clay C. G., Sithol S., Richards G. A., Poirel L., Nordmann P., Emergence of New Delhi metallo-beta-lactamase (NDM-1) and Klebsiella pneumoniae carbapenemase (KPC-2) in South Africa. Journal of Clinical Microbiology 2012 50 2 525 527 2-s2.0-84856162360 10.1128/JCM.05956-11
5. Queenan A. M., Bush K., Carbapenemases: the versatile β -lactamases. Clinical Microbiology Reviews 2007 20 3 440 458 2-s2.0-34547422759 10.1128/CMR.00001-07 (Pubitemid 47175013)
6. Nordmann P., Naas T., Poirel L., Global spread of carbapenemase producing Enterobacteriaceae. Emerging Infectious Diseases 2011 17 10 1791 1798 2-s2.0-80053260150 http://dx.doi.org/10.3201/eid1710.110655
7. Carrër A., Poirel L., Yilmaz M., Akan Ö. A., Feriha C., Cuzon G., Matar G., Honderlick P., Nordmann P., Spread of OXA-48-encoding plasmid in Turkey and beyond. Antimicrobial Agents and Chemotherapy 2010 54 3 1369 1373 2-s2.0-77149120744 10.1128/AAC.01312-09
8. Poirel L., Revathi G., Bernabeu S., Nordmann P., Detection of NDM-1-producing Klebsiella pneumoniae in Kenya. Antimicrobial Agents and Chemotherapy 2011 55 2 934 936 2-s2.0-78751698065 10.1128/AAC.01247-10
9. Pitout J. D. D., Revathi G., Chow B. L., Kabera B., Kariuki S., Nordmann P., Poirel L., Metallo- β -lactamase-producing Pseudomonas aeruginosa isolated from a large tertiary centre in Kenya. Clinical Microbiology and Infection 2008 14 8 755 759 2-s2.0-48449083640 10.1111/j.1469-0691.2008.02030.x
10. Hammami S., Boutiba-Ben Boubaker I., Ghozzi R., Saidani M., Amine S., Ben Redjeb S., Nosocomial outbreak of imipenem-resistant Pseudomonas aeruginosa producing VIM-2 metallo- β -lactamase in a kidney transplantation unit. Diagnostic Pathology 2011 6 1, article 106 2-s2.0-80054988925 10.1186/1746-1596-6-106
11. Coetzee J., Brink A., The emergence of carbapenem resistance in Enterobacteriaceae in South Africa. Southern African Journal of Epidemiology and Infection 2011 26 4 239 240
12. Kayange N., Kamugisha E., Mwizamholya D. L., Jeremiah S., Mshana S. E., Predictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza-Tanzania. BMC Pediatrics 2010 10, article 39 2-s2.0-77954042696 10.1186/1471-2431-10-39
13. Mshana S. E., Kamugisha E., Mirambo M., Chakraborty T., Lyamuya E. F., Prevalence of multiresistant gram-negative organisms in a tertiary hospital in Mwanza, Tanzania. BMC Research Notes 2009 2, article 49 2-s2.0-75749144861 10.1186/1756-0500-2-49
14. CLSI, Standards for Antimicrobial Disk Susceptibility Tests. Approved Standard 2010 9th Wayne, Pa, USA Clinical and Laboratory Standards Institute Document M2-A9
15. Dallenne C., da Costa A., Decré D., Favier C., Arlet G., Development of a set of multiplex PCR assays for the detection of genes encoding important β -lactamases in Enterobacteriaceae. Journal of Antimicrobial Chemotherapy 2010 65 3 490 495 2-s2.0-77950330816 10.1093/jac/dkp498
16. Holmes D. S., Quigley M., A rapid boiling method for the preparation of bacterial plasmids. Analytical Biochemistry 1981 114 1 193 197 2-s2.0-0019862344 (Pubitemid 11011463)
17. Fischer J., Rodríguez I., Schmoger S., Friese A., Roesler U., Helmuth R., Guerra B., Escherichia coli producing VIM-1 carbapenemase isolated on a pig farm. Journal of Antimicrobial Chemotherapy 2012 67 7 1793 1795
18. Kumarasamy K. K., Toleman M. A., Walsh T. R., Bagaria J., Butt F., Balakrishnan R., Chaudhary U., Doumith M., Giske C. G., Irfan S., Krishnan P., Kumar A. V., Maharjan S., Mushtaq S., Noorie T., Paterson D. L., Pearson A., Perry C., Pike R., Rao B., Ray U., Sarma J. B., Sharma M., Sheridan E., Thirunarayan M. A., Turton J., Upadhyay S., Warner M., Welfare W., Livermore D. M., Woodford N., Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. The Lancet Infectious Diseases 2010 10 9 597 602 2-s2.0-77955917495 10.1016/S1473-3099(10)70143-2
19. Pitout J. D. D., Gregson D. B., Poirel L., McClure J.-A., Le P., Church D. L., Detection of Pseudomonas aeruginosa producing metallo- β -lactamases in a large centralized laboratory. Journal of Clinical Microbiology 2005 43 7 3129 3135 2-s2.0-22144483439 10.1128/JCM.43.7.3129-3135.2005 (Pubitemid 40981312)
20. Hammerum A. M., Toleman M. A., Hansen F., Kristensen B., Lester C. H., Walsh T. R., Fuursted K., Global spread of New Delhi metallo- β -lactamase 1. The Lancet Infectious Diseases 2010 10 12 829 830 2-s2.0-78649426967 10.1016/S1473-3099(10)70276-0
21. Lascols C., Hackel M., Marshall S. H., Hujer A. M., Bouchillon S., Badal R., Hoban D., Bonomo R. A., Increasing prevalence and dissemination of NDM-1 metallo- β -lactamase in India: data from the SMART study (2009). Journal of Antimicrobial Chemotherapy 2011 66 9 1992 1997 2-s2.0-80051695875 10.1093/jac/dkr240
22. Nordmann P., Dortet L., Poirel L., Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends in Molecular Medicine 2012 18 5 263 272 2-s2.0-84860516573 10.1016/j.molmed.2012.03.003
23. Webster D. P., Gaulton T., Woodford N., Pike R., Turton J., Perry C., Bowler I. C. J. W., Emergence of carbapenem resistance due to porin loss in an extended-spectrum β -lactamase (ESBL)-producing Klebsiella pneumoniae strain during meropenem therapy. International Journal of Antimicrobial Agents 2010 36 6 575 576 2-s2.0-78249260635 10.1016/j.ijantimicag.2010.08.003
24. Potron A., Poirel L., Rondinaud E., Nordmann P., Intercontinental spread of OXA-48 beta-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011. Euro Surveillance 2013 18 31 20549
25. Mshana S. E., Imirzalioglu C., Hain T., Domann E., Lyamuya E. F., Chakraborty T., Multiple ST clonal complexes, with a predominance of ST131, of Escherichia coli harbouring blaCTX-M-15 in a tertiary hospital in Tanzania. Clinical Microbiology and Infection 2011 17 8 1279 1282 2-s2.0-79960698232 10.1111/j.1469-0691.2011.03518.x
26. Mshana S. E., Hain T., Domann E., Lyamuya E. F., Chakraborty T., Imirzalioglu C., Predominance of Klebsiella pneumoniae ST14 carrying CTX-M-15 causing neonatal sepsis in Tanzania. BMC Infectious Diseases 2013 13 1, article 466
27. Docquier J.-D., Lamotte-Brasseur J., Galleni M., Amicosante G., Frère J.-M., Rossolini G. M., On functional and structural heterogeneity of VIM-type metallo- β -lactamases. Journal of Antimicrobial Chemotherapy 2003 51 2 257 266 2-s2.0-0037329156 10.1093/jac/dkg067 (Pubitemid 36231144)
28. Gupta N., Limbago B. M., Patel J. B., Kallen A. J., Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clinical Infectious Diseases 2011 53 1 60 67 2-s2.0-79958818528 10.1093/cid/cir202
29. Nordmann P., Poirel L., Toleman M. A., Walsh T. R., Does broad-spectrum β -lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? Journal of Antimicrobial Chemotherapy 2011 66 4 689 692 2-s2.0-79952789048 10.1093/jac/dkq520